top of page
The Professional Network for Healthcare Experts
HanchorBio partners with Taiwan Cancer Moonshot team to advance precision immunotherapy development
The collaboration combines HanchorBio's immuno-oncology platform with Taiwan's national precision oncology programme to support biomarker-driven clinical development and translational research.
nuaxia
3 days ago2 min read
FDA grants accelerated approval to Tudriqev for PD-1-refractory advanced melanoma
The engineered oncolytic viral therapy, used with nivolumab, provides a new treatment option for adults with unresectable cutaneous melanoma that has progressed despite prior PD-1-based immunotherapy.
nuaxia
Aug 72 min read
bottom of page